Medications for Nonketotic Hyperosmolar Syndrome
Other names: Diabetic Hyperglycemic Hyperosmolar Coma; HONK, hyperosmolar non-ketotic coma; NKHHC; Nonketotic Hyperglycemic Hyperosmolar Coma
Drugs used to treat Nonketotic Hyperosmolar Syndrome
The following list of medications are in some way related to, or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
Humalog | Rate | Add review | Rx | ||||
Generic name: insulin lispro systemic Drug class: insulin For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Novolog | Rate | Add review | Rx | ||||
Generic name: insulin aspart systemic Drug class: insulin For consumers: dosage, interactions, side effects |
|||||||
Humulin R | Rate | Add review | OTC | ||||
Generic name: insulin regular systemic Drug class: insulin For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
insulin lispro | Rate | Add review | Rx | ||||
Generic name: insulin lispro systemic Brand name: Humalog Drug class: insulin For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
insulin regular | Rate | Add review | Rx/OTC | ||||
Generic name: insulin regular systemic Brand names: Humulin R, Novolin R Drug class: insulin For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, Prescribing Information |
|||||||
insulin aspart | Rate | Add review | Rx | ||||
Generic name: insulin aspart systemic Brand names: Novolog, NovoLog FlexPen, NovoLog PenFill Drug class: insulin For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
insulin glulisine | Rate | Add review | Rx | ||||
Generic name: insulin glulisine systemic Brand name: Apidra Drug class: insulin For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
Novolin R | Rate | Add review | OTC | ||||
Generic name: insulin regular systemic Drug class: insulin For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Apidra | Rate | Add review | Rx | ||||
Generic name: insulin glulisine systemic Drug class: insulin For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
NovoLog FlexPen | Rate | Add review | Rx | ||||
Generic name: insulin aspart systemic Drug class: insulin For consumers: dosage, interactions, side effects |
|||||||
NovoLog PenFill | Rate | Add review | Rx | ||||
Generic name: insulin aspart systemic Drug class: insulin For consumers: dosage, interactions, side effects |
|||||||
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription Only. |
OTC | Over the Counter. |
Rx/OTC | Prescription or Over the Counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.